Kim Hyun-Sook, Park Hyunjin, Cho In-Young, Paik Hyun-Dong, Park Eunju
Major in Food and Nutrition, Division of Human Ecology, College of Human Ecology, Sookmyung Women's University, Masan, Republic of Korea.
J Med Food. 2006 Fall;9(3):321-7. doi: 10.1089/jmf.2006.9.321.
A probiotic is a viable microbial dietary supplement that has beneficial effects such as prevention and treatment of specific gastrointestinal disorders, including counteracting gut barrier dysfunction associated with inflammation and infection. Probiotic Bacillus polyfermenticus, which is commonly called Bispan strain, has been appropriately used for the treatment of long-term intestinal disorders. The use of B. polyfermenticus for immune-related chronic intestinal disease may be appropriate considering that about 80% of the body's immune system is localized in the gastrointestinal tract. The current study aimed to evaluate the effect of probiotic B. polyfermenticus on the immune response of human subjects through the quantification of immune cell population and serum levels of immunoglobulins (Igs). Twenty-five male subjects, 20-35 years of age, were randomly assigned to either a control group (n =12) supplemented with a placebo or the experimental group (n = 13) supplemented with B. polyfermenticus tablets at a dose of 3.1 x 10(8) colony-forming units/day for 8 weeks. Dietary intake analyses from 3-day dietary records from three consecutive days including one weekend day and two weekdays revealed no significant differences in total energy and nutrient intakes between the two groups. The humoral immune response was monitored by the number of total B lymphocytes and serum concentrations of IgG, IgA, and IgM. To investigate the changes in immune cell populations, percentages of total T lymphocytes, CD4+ helper T cells, CD8+ cytotoxic T cells, and CD56+ natural killer (NK) cells were quantified. The concentration of IgG in the experimental group was 12% higher than in the placebo group after 8 weeks of Bispan supplementation. Also, the percentages of CD4+ helper T cells, CD8+cytotoxic T cells, and CD56+ NK cells in the Bispan strain-supplemented group were 32%, 28%, and 35% higher, respectively, compared with the control group. Because of a higher increment of the CD4+ T cell subset than CD8+ T cells, the ratio of CD4+/CD8+ T cells was greater in the experimental group. This study suggests that the supplementation of B. polyfermenticus has a potentially positive effect on immune function by enhancing IgG production as well as by modulating the number of immune cell population such as CD4+ and CD8+ T cells and NK cells.
益生菌是一种可行的微生物膳食补充剂,具有有益作用,如预防和治疗特定的胃肠道疾病,包括对抗与炎症和感染相关的肠道屏障功能障碍。益生菌多发酵芽孢杆菌,通常称为比斯潘菌株,已被适当地用于治疗长期肠道疾病。考虑到人体约80%的免疫系统位于胃肠道,使用多发酵芽孢杆菌治疗免疫相关的慢性肠道疾病可能是合适的。本研究旨在通过量化免疫细胞群体和血清免疫球蛋白(Igs)水平,评估益生菌多发酵芽孢杆菌对人体免疫反应的影响。25名年龄在20至35岁之间的男性受试者被随机分为对照组(n = 12),补充安慰剂,或实验组(n = 13),补充多发酵芽孢杆菌片剂,剂量为3.1 x 10(8) 菌落形成单位/天,持续8周。连续三天(包括一个周末日和两个工作日)的3天饮食记录的饮食摄入分析显示,两组之间的总能量和营养摄入量没有显著差异。通过总B淋巴细胞数量和IgG、IgA和IgM的血清浓度监测体液免疫反应。为了研究免疫细胞群体的变化,对总T淋巴细胞、CD4+辅助性T细胞、CD8+细胞毒性T细胞和CD56+自然杀伤(NK)细胞的百分比进行了量化。补充比斯潘8周后,实验组的IgG浓度比安慰剂组高12%。此外,与对照组相比,补充比斯潘菌株组的CD4+辅助性T细胞、CD8+细胞毒性T细胞和CD56+ NK细胞的百分比分别高32%、28%和35%。由于CD4+ T细胞亚群的增加高于CD8+ T细胞,实验组中CD4+/CD8+ T细胞的比例更大。本研究表明,补充多发酵芽孢杆菌通过增强IgG产生以及调节免疫细胞群体数量,如CD4+和CD8+ T细胞以及NK细胞,对免疫功能具有潜在的积极影响。